- Home
- ONC vs CHTR Comparison
ONC vs CHTR Comparison
Compare ONC & CHTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- CHTR
- Stock Information
- Founded
- ONC 2010
- CHTR 1993
- Country
- ONC Switzerland
- CHTR United States
- Employees
- ONC N/A
- CHTR N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- CHTR Cable & Other Pay Television Services
- Sector
- ONC Health Care
- CHTR Telecommunications
- Exchange
- ONC Nasdaq
- CHTR Nasdaq
- Market Cap
- ONC 37.2B
- CHTR 35.8B
- IPO Year
- ONC N/A
- CHTR 1999
- Fundamental
- Price
- ONC $313.67
- CHTR $277.58
- Analyst Decision
- ONC Strong Buy
- CHTR Buy
- Analyst Count
- ONC 9
- CHTR 15
- Target Price
- ONC $335.78
- CHTR $396.07
- AVG Volume (30 Days)
- ONC 410.3K
- CHTR 2.4M
- Earning Date
- ONC 08-06-2025
- CHTR 07-25-2025
- Dividend Yield
- ONC N/A
- CHTR N/A
- EPS Growth
- ONC N/A
- CHTR 16.69
- EPS
- ONC N/A
- CHTR 36.55
- Revenue
- ONC $4,562,002,000.00
- CHTR $55,222,000,000.00
- Revenue This Year
- ONC $865.19
- CHTR $2.21
- Revenue Next Year
- ONC $21.12
- CHTR $1.35
- P/E Ratio
- ONC N/A
- CHTR $7.60
- Revenue Growth
- ONC 47.33
- CHTR 1.03
- 52 Week Low
- ONC $170.99
- CHTR $254.67
- 52 Week High
- ONC $330.63
- CHTR $437.06
- Technical
- Relative Strength Index (RSI)
- ONC 61.68
- CHTR 38.55
- Support Level
- ONC $301.33
- CHTR $264.22
- Resistance Level
- ONC $330.63
- CHTR $271.03
- Average True Range (ATR)
- ONC 9.12
- CHTR 6.65
- MACD
- ONC -0.19
- CHTR 5.42
- Stochastic Oscillator
- ONC 66.43
- CHTR 82.04
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About CHTR Charter Communications Inc. New
Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 58 million US homes and businesses, around 35% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest US cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (Los Angeles Lakers), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1. Charter plans to acquire cable peer Cox.